Market's view on Empresaria Group
Published on April 2024
- Empresaria’s FY 2023 results align with the January statement, despite challenging recruitment markets. The company has taken steps to reduce costs and complexity, focusing on core sectors, preparing for potential market recovery. Dividend expectations for 2023 have been adjusted to 1.0p.
- A stock watcher criticizes the management of EMR, highlighting a discrepancy in performance compared to prospering companies in the same sector, suggesting a need for management overhaul.
- Frustration is expressed over EMR’s significant market cap decline (~60%) during the current CEO’s tenure over the past four years.
- Dissatisfaction with the lack of comments and trades, combined with a call for changes in the company’s broker and PR strategies.
- Concerns are raised about the company’s share buy-back decisions, questioning the wisdom of buying back shares at higher prices given current market conditions.
- A suggestion is made that the best course of action for the company might be to go private, considering the current situation and low market interest.
- There are critiques regarding the management’s recent share purchases, questioning the timing and decision-making process knowing the company’s challenges.
- Comments on the company’s market cap to profitability ratio are generally positive, indicating a reasonable balance despite the challenges.
- A general sentiment of neglect and lack of interest in the company’s shares is noted, with a call for increased efforts in raising the company’s profile and investor engagement.